As of 2025-07-16, the Relative Valuation of Nuvation Bio Inc (NUVB) is (33.23) USD. This relative valuation is based on P/E multiples. With the latest stock price at 2.13 USD, the upside of Nuvation Bio Inc based on Relative Valuation is -1660.0%.
The range of the Relative Valuation is (32.16) - (33.01) USD.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 17.5x - 18.6x | 17.7x |
| Forward P/E multiples | 18.1x - 20.8x | 19.7x |
| Fair Price | (32.16) - (33.01) | (33.23) |
| Upside | -1609.9% - -1650.0% | -1660.0% |
| Date | P/E |
| 2025-07-15 | -1.20 |
| 2025-07-14 | -1.20 |
| 2025-07-11 | -1.24 |
| 2025-07-10 | -1.30 |
| 2025-07-09 | -1.33 |
| 2025-07-08 | -1.15 |
| 2025-07-07 | -1.17 |
| 2025-07-03 | -1.18 |
| 2025-07-02 | -1.15 |
| 2025-07-01 | -1.09 |
| 2025-06-30 | -1.10 |
| 2025-06-27 | -1.09 |
| 2025-06-26 | -1.11 |
| 2025-06-25 | -1.06 |
| 2025-06-24 | -1.15 |
| 2025-06-23 | -1.14 |
| 2025-06-20 | -1.11 |
| 2025-06-18 | -1.01 |
| 2025-06-17 | -0.96 |
| 2025-06-16 | -1.05 |
| 2025-06-13 | -0.97 |
| 2025-06-12 | -1.02 |
| 2025-06-11 | -1.24 |
| 2025-06-10 | -1.42 |
| 2025-06-09 | -1.41 |
| 2025-06-06 | -1.40 |
| 2025-06-05 | -1.40 |
| 2025-06-04 | -1.38 |
| 2025-06-03 | -1.38 |
| 2025-06-02 | -1.32 |
| 2025-05-30 | -1.19 |
| 2025-05-29 | -1.27 |
| 2025-05-28 | -1.24 |
| 2025-05-27 | -1.26 |
| 2025-05-23 | -1.29 |
| 2025-05-22 | -1.27 |
| 2025-05-21 | -1.14 |
| 2025-05-20 | -1.22 |
| 2025-05-19 | -1.29 |
| 2025-05-16 | -1.27 |
| 2025-05-15 | -1.26 |
| 2025-05-14 | -1.22 |
| 2025-05-13 | -1.23 |
| 2025-05-12 | -1.21 |
| 2025-05-09 | -1.18 |
| 2025-05-08 | -1.18 |
| 2025-05-07 | -1.15 |
| 2025-05-06 | -1.18 |
| 2025-05-05 | -1.34 |
| 2025-05-02 | -1.38 |